Premacure

Shire acquires Premacure

Wednesday, March 13, 2013

Global specialty biopharmaceutical company Shire has acquired Premacure, a Swedish privately held biotechnology company developing a protein replacement therapy, currently in phase II development for the prevention of retinopathy of prematurity (ROP).

[Read More]